Editorial: a paradigm shift in NUDT15 assessment-towards predictive and personalised medicine in Crohn's disease? Authors' reply

Aliment Pharmacol Ther. 2022 Mar;55(6):742-743. doi: 10.1111/apt.16813.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Crohn Disease* / diagnosis
  • Crohn Disease* / drug therapy
  • Crohn Disease* / genetics
  • Humans
  • Precision Medicine